マーケットレポート詳細
高薬理活性原薬(HPAPI)の世界市場：タイプ別、用途別2027年予測
High Potency APIs Market/HPAPI Market by Type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), Manufacturers (Captive, Merchant), Application (Oncology, Hormonal Imbalance, Glaucoma) Region - Global forecast to 2027
- 出版元：MarketsandMarkets
出版元について - 発行年：2022年5月
- 定価 ：Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文270ページになります。
- 商品コード：MAM2935
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
高薬理活性原薬(HPAPI)世界市場規模は2022年で245億ドル、2027年に396億ドル、市場の平均年成長率は10.1%で推移する見込みです。
レポートは高薬理活性原薬(HPAPI)の世界市場について2027年までの市場予測データ(金額US$)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測（合成タイプ別市場、製造業者タイプ別市場、等）を中心に構成されています。また競合状況、主要企業情報（12社）、市場ダイナミクス、市場シェア分析、競合状況などの分析も加味し、高薬理活性原薬(HPAPI)市場の動向および今後成長性を詳細にレポートしています。
【レポート構成概要】
◆高薬理活性原薬(HPAPI)の世界市場予測2020-2027年
・市場規模(US$)
◆タイプ別、市場-2027年
・革新的HPAPI
・ジェネリックHPAPI
※(市場規模US$)
◆合成タイプ別、市場-2027年
合成API
・革新的合成API
・ジェネリック合成API
バイオテックAPI
(タイプ別)
・革新的バイオテック
・バイオシミラー
(製品別)
・モノクローナル抗体
・ワクチン
・組換えタンパク質
※(市場規模US$)
◆製造業者タイプ別、市場-2027年
内製APIメーカー
外販用APIメーカー
(タイプ別)
・革新的マーチャント
・ジェネリックマーチャント
(合成タイプ別)
・合成API
・バイオテックAPI
※(市場規模US$)
◆用途別、市場-2027年
・腫瘍学
・ホルモン失調
・緑内障
・その他治療用途
※(市場規模US$)
◆主要国地域別市場-2027年
北米
・米国、カナダ
欧州
・ドイツ、フランス、英国
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・その他アジア太平洋
その他地域
※国地域別に全セグメントの細分化データ掲載
◆市場分析
・市場ダイナミクス(ドライバー、障壁、機会、課題)
・COVID-19の影響
・規制分析
・ファイブフォース分析
・技術分析
・市場シェア分析
・競合状況
◆高薬理活性原薬(HPAPI)の主要企業プロフィール動向
・PFIZER INC.
・NOVARTIS INTERNATIONAL AG
・SANOFI
・F. HOFFMANN-LA ROCHE
・BRISTOL-MYERS SQUIBB COMPANY
・BOEHRINGER-INGELHEIM
・TEVA PHARMACEUTICAL INDUSTRY LTD.
・ELI LILY AND COMPANY
・MERCK & CO., INC.
・ABBVIE INC.
・VIATRIS INC.
・BAYER
（全270頁）
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1 INTRODUCTION 30
1.1 STUDY OBJECTIVES 30
1.2 MARKET DEFINITION 30
1.2.1 INCLUSIONS & EXCLUSIONS 30
1.3 STUDY SCOPE 31
1.3.1 MARKETS COVERED 31
・ FIGURE 1 HPAPI MARKET: GEOGRAPHIC SCOPE 32
1.3.2 YEARS CONSIDERED 32
1.4 CURRENCY 33
1.5 LIMITATIONS 33
1.6 SUMMARY OF CHANGES 33
1.7 STAKEHOLDERS 34
2 RESEARCH METHODOLOGY 35
・ FIGURE 2 RESEARCH DESIGN 35
2.1 SECONDARY DATA 36
2.1.1 SECONDARY SOURCES 36
2.2 PRIMARY DATA 37
・ FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: HPAPI MARKET 37
2.2.1 KEY DATA FROM PRIMARY SOURCES 38
2.2.2 PRIMARY INSIGHTS 38
2.3 MARKET SIZE ESTIMATION 39
・ FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 39
・ FIGURE 5 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 40
2.4 MARKET GROWTH RATE PROJECTIONS 40
・ FIGURE 6 HPAPI MARKET: CAGR PROJECTIONS 41
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION 41
・ FIGURE 7 DATA TRIANGULATION 42
2.6 RESEARCH ASSUMPTIONS 43
2.7 RISK ANALYSIS 43
3 EXECUTIVE SUMMARY 44
・ FIGURE 8 HPAPI MARKET, BY TYPE, 2021 VS. 2027 44
・ FIGURE 9 HPAPI MARKET, BY TYPE OF MANUFACTURER, 2021 VS. 2027 45
・ FIGURE 10 HPAPI MARKET, BY TYPE OF SYNTHESIS, 2021 VS. 2027 46
・ FIGURE 11 HPAPI MARKET, BY THERAPEUTIC APPLICATION, 2021 VS. 2027 47
・ FIGURE 12 GEOGRAPHIC SNAPSHOT OF HPAPI MARKET (2022–2027) 48
4 PREMIUM INSIGHTS 49
4.1 HPAPI: MARKET OVERVIEW 49
・ FIGURE 13 INCREASING DEMAND FOR ONCOLOGY DRUGS AND ANTIBODY-DRUG CONJUGATES TO DRIVE MARKET GROWTH 49
4.2 HPAPI MARKET, BY TYPE, (2021 VS. 2027) 50
・ FIGURE 14 INNOVATIVE HPAPIS TO DOMINATE THE GLOBAL MARKET IN 2027 50
4.3 HPAPI MARKET, BY TYPE OF SYNTHESIS, (2021 VS. 2027) 50
・ FIGURE 15 SYNTHETIC HPAPIS TO DOMINATE MARKET SHARE IN 2021 50
4.4 HPAPI MARKET BY THERAPEUTIC AREA (2021–2027) 51
・ FIGURE 16 ONCOLOGY SEGMENT TO REGISTER HIGHEST CAGR
DURING FORECAST PERIOD 51
4.5 GEOGRAPHICAL SNAPSHOT OF HPAPI MARKET 52
・ FIGURE 17 CHINA & INDIA TO REGISTER HIGH GROWTH RATES DURING 2022–2027 52
5 MARKET OVERVIEW 53
5.1 INTRODUCTION 53
5.2 MARKET DYNAMICS 53
・ FIGURE 18 HPPAI MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 53
5.2.1 DRIVERS 54
5.2.1.1 INCREASING DEMAND FOR ONCOLOGY DRUGS 54
・ TABLE 1 PIPELINE OF ONCOLOGY DRUGS (2021) 54
5.2.1.2 GROWING DEMAND FOR ANTIBODY-DRUG CONJUGATES 55
5.2.1.3 INCREASING FOCUS OF LEADING PHARMACEUTICAL COMPANIES ON HPAPIS 55
5.2.1.4 ADVANCEMENTS IN HPAPI MANUFACTURING TECHNOLOGIES 56
5.2.1.5 GROWING FOCUS ON PRECISION MEDICINE 56
5.2.2 RESTRAINTS 57
5.2.2.1 INCREASING REQUIREMENT OF LARGE INVESTMENTS FOR EMPLOYEE SAFETY 57
5.2.2.2 DISCREPANCIES IN HPAPI BANDING SYSTEMS 57
5.2.2.3 RISING NUMBER OF UNCERTAINTIES ASSOCIATED WITH PRODUCTS 58
5.2.2.4 HIGH RISK OF CROSS-CONTAMINATION 58
5.2.3 OPPORTUNITIES 58
5.2.3.1 GROWING OPPORTUNITIES FOR CMOS AND CDMOS 58
5.2.3.2 INCREASING OPPORTUNITIES FOR COMPANIES IN EMERGING MARKETS 58
5.2.4 CHALLENGES 59
5.2.4.1 NEED FOR APPROPRIATE PROCESS DESIGNS 59
5.2.4.2 CONSTANT EVOLUTION OF INDUSTRY STANDARDS AND TECHNOLOGIES 59
5.3 IMPACT OF COVID-19 ON HPAPI MARKET 59
5.4 REGULATORY ANALYSIS 60
5.4.1 HANDLING HPAPI 60
5.4.2 THIRD PARTY CERTIFICATION 61
5.4.3 CONTAINMENT STRATEGIES 61
5.4.4 CHALLENGES 62
5.5 PORTER’S FIVE FORCES ANALYSIS 62
・ TABLE 2 HPAPI MARKET: PORTER’S FIVE FORCES ANALYSIS 62
5.5.1 THREAT OF NEW ENTRANTS 63
5.5.2 THREAT OF SUBSTITUTES 63
5.5.3 BARGAINING POWER OF SUPPLIERS 63
5.5.4 BARGAINING POWER OF BUYERS 63
5.5.5 DEGREE OF COMPETITION 63
5.6 TECHNOLOGY ANALYSIS 63
5.6.1 HANDLING POTENT COMPOUNDS 63
5.6.2 CONTROLS 64
5.6.3 SAFETY ASSESSMENT AND STANDARD OPERATING PROCEDURES 64
5.6.4 DEDICATED EQUIPMENT AND SYSTEMS 65
5.6.5 EXPERTISE AND TRAINING 65
5.6.6 COMBUSTIBLE DUST HANDLING 65
5.6.7 SUI・ TABLE PERSONAL PROTECTIVE EQUIPMENT 65
6 HPAPI CLASSIFICATION AND OVERVIEW 66
6.1 INTRODUCTION 66
6.2 HPAPI INGREDIENTS CLASSIFICATION AS PER SAFEBRIDGE CONSULTANTS 66
・ TABLE 3 CATEGORIES OF HPAPIS 66
・ TABLE 4 POTENCY CLASSIFICATION SYSTEM 67
7 HPAPI MARKET, BY TYPE 69
7.1 INTRODUCTION 70
・ FIGURE 19 INNOVATIVE HPAPIS SEGMENT TO DOMINATE HPAPI MARKET 70
・ TABLE 5 HPAPI MARKET, BY TYPE, 2020–2027 (USD MILLION) 70
7.2 INNOVATIVE HPAPIS 71
・ TABLE 6 INNOVATIVE HPAPIS MARKET, BY REGION, 2020–2027 (USD MILLION) 71
・ TABLE 7 NORTH AMERICA: INNOVATIVE HPAPIS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 72
・ TABLE 8 EUROPE: INNOVATIVE HPAPIS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 72
・ TABLE 9 ASIA: INNOVATIVE HPAPIS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 73
7.3 GENERIC HPAPIS 73
・ TABLE 10 GENERIC HPAPIS MARKET, BY REGION, 2020–2027 (USD MILLION) 74
・ TABLE 11 NORTH AMERICA: GENERIC HPAPIS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 74
・ TABLE 12 EUROPE: GENERIC HPAPIS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 75
・ TABLE 13 ASIA: GENERIC HPAPIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 75
8 HPAPI MARKET, BY TYPE OF SYNTHESIS 76
8.1 INTRODUCTION 77
・ FIGURE 20 SYNTHETIC SEGMENT TO DOMINATE MARKET IN 2021 77
・ TABLE 14 HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD MILLION) 77
8.2 SYNTHETIC APIS 78
・ TABLE 15 SYNTHETIC APIS MARKET, BY REGION, 2020–2027 (USD MILLION) 78
・ TABLE 16 NORTH AMERICA: SYNTHETIC APIS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 79
・ TABLE 17 EUROPE: SYNTHETIC APIS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 79
・ TABLE 18 ASIA: SYNTHETIC APIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 80
8.2.1 SYNTHETIC APIS MARKET, BY TYPE 80
・ TABLE 19 SYNTHETIC APIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 80
・ TABLE 20 INNOVATIVE SYNTHETIC APIS 81
・ TABLE 21 INNOVATIVE SYNTHETIC APIS MARKET, BY REGION,
2020–2027 (USD MILLION) 81
・ TABLE 22 NORTH AMERICA: INNOVATIVE SYNTHETIC APIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 81
・ TABLE 23 EUROPE: INNOVATIVE SYNTHETIC APIS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 82
・ TABLE 24 ASIA: INNOVATIVE SYNTHETIC APIS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 82
8.2.2 GENERIC SYNTHETIC APIS 83
・ TABLE 25 GENERIC SYNTHETIC APIS MARKET, BY REGION, 2020–2027 (USD MILLION) 83
・ TABLE 26 NORTH AMERICA: GENERIC SYNTHETIC APIS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 83
・ TABLE 27 EUROPE: GENERIC SYNTHETIC APIS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 84
・ TABLE 28 ASIA: GENERIC SYNTHETIC APIS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 84
8.3 BIOTECH APIS 85
・ TABLE 29 BIOTECH APIS MARKET, BY REGION, 2020–2027 (USD MILLION) 85
・ TABLE 30 NORTH AMERICA: BIOTECH APIS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 86
・ TABLE 31 EUROPE: BIOTECH APIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 86
・ TABLE 32 ASIA: BIOTECH APIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 87
8.3.1 BIOTECH APIS MARKET, BY TYPE 87
・ TABLE 33 BIOTECH APIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 87
8.3.2 INNOVATIVE BIOTECH APIS 88
・ TABLE 34 INNOVATIVE BIOTECH APIS MARKET, BY REGION, 2020–2027 (USD MILLION) 88
・ TABLE 35 NORTH AMERICA: INNOVATIVE BIOTECH APIS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 88
・ TABLE 36 EUROPE: INNOVATIVE BIOTECH APIS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 89
・ TABLE 37 ASIA: INNOVATIVE BIOTECH APIS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 89
8.3.3 BIOSIMILARS 90
・ TABLE 38 BIOSIMILARS MARKET, BY REGION, 2020–2027 (USD MILLION) 90
・ TABLE 39 NORTH AMERICA: BIOSIMILARS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 91
・ TABLE 40 EUROPE: BIOSIMILARS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 91
・ TABLE 41 ASIA: BIOSIMILARS INGREDIENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 92
8.3.4 BIOTECH APIS MARKET, BY PRODUCT 92
・ TABLE 42 BIOTECH APIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 92
8.3.5 MONOCLONAL ANTIBODIES 93
・ TABLE 43 MONOCLONAL ANTIBODIES MARKET, BY REGION,
2020–2027 (USD MILLION) 93
8.3.6 VACCINES 93
・ TABLE 44 VACCINES MARKET, BY REGION, 2020–2027 (USD MILLION) 94
8.3.7 RECOMBINANT PROTEINS 94
・ TABLE 45 RECOMBINANT PROTEINS MARKET, BY REGION, 2020–2027 (USD MILLION) 95
9 HPAPI MARKET, BY TYPE OF MANUFACTURER 96
9.1 INTRODUCTION 97
・ FIGURE 21 CAPTIVE HPAPI MANUFACTURERS SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2021 97
・ TABLE 46 HPAPI MARKET, BY TYPE OF MANUFACTURER, 2020–2027 (USD MILLION) 98
9.2 CAPTIVE API MANUFACTURERS 98
・ TABLE 47 CAPTIVE API MANUFACTURERS MARKET, BY REGION,
2020–2027 (USD MILLION) 99
・ TABLE 48 NORTH AMERICA: CAPTIVE API MANUFACTURERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 99
・ TABLE 49 EUROPE: CAPTIVE API MANUFACTURERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 100
・ TABLE 50 ASIA: CAPTIVE API MANUFACTURERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 100
9.3 MERCHANT API MANUFACTURERS 101
・ TABLE 51 MERCHANT API MANUFACTURERS MARKET, BY REGION,
2020–2027 (USD MILLION) 101
・ TABLE 52 NORTH AMERICA: MERCHANT API MANUFACTURERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 102
・ TABLE 53 EUROPE: MERCHANT API MANUFACTURERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 102
・ TABLE 54 ASIA: MERCHANT API MANUFACTURERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 103
9.3.1 MERCHANT API MANUFACTURERS MARKET BY TYPE 103
・ TABLE 55 MERCHANT API MANUFACTURERS MARKET BY TYPE,
2020–2027 , (USD MILLION) 103
9.3.2 INNOVATIVE MERCHANT API MANUFACTURERS 104
・ TABLE 56 INNOVATIVE MERCHANT API MANUFACTURERS MARKET, BY REGION,
2020–2027 (USD MILLION) 104
・ TABLE 57 NORTH AMERICA: INNOVATIVE MERCHANT API MANUFACTURERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 104
・ TABLE 58 EUROPE: INNOVATIVE MERCHANT API MANUFACTURERS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 105
・ TABLE 59 ASIA: INNOVATIVE MERCHANT API MANUFACTURERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 105
9.3.3 GENERIC MERCHANT API MANUFACTURERS 106
・ TABLE 60 GENERIC MERCHANT API MANUFACTURERS MARKET, BY REGION,
2020–2027 (USD MILLION) 106
・ TABLE 61 NORTH AMERICA: GENERIC MERCHANT API MANUFACTURERS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 106
・ TABLE 62 EUROPE: GENERIC MERCHANT API MANUFACTURERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 107
・ TABLE 63 ASIA: GENERIC MERCHANT API MANUFACTURERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 107
9.3.4 MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS 108
・ TABLE 64 MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS,
2020–2027 , (USD MILLION) 108
9.3.5 SYNTHETIC API MANUFACTURERS 108
・ TABLE 65 SYNTHETIC API MANUFACTURERS MARKET, BY REGION,
2020–2027 (USD MILLION) 108
・ TABLE 66 NORTH AMERICA: SYNTHETIC API MANUFACTURERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 109
・ TABLE 67 EUROPE: SYNTHETIC API MANUFACTURERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 109
・ TABLE 68 ASIA: SYNTHETIC API MANUFACTURERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 110
9.3.6 BIOTECH API MANUFACTURERS 110
・ TABLE 69 BIOTECH API MANUFACTURERS MARKET, BY REGION,
2020–2027 (USD MILLION) 111
・ TABLE 70 NORTH AMERICA: BIOTECH API MANUFACTURERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 111
・ TABLE 71 EUROPE: BIOTECH API MANUFACTURERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 112
・ TABLE 72 ASIA: BIOTECH API MANUFACTURERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 112
10 HPAPI MARKET, BY THERAPEUTIC APPLICATION 113
10.1 INTRODUCTION 114
・ FIGURE 22 ONCOLOGY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 114
・ TABLE 73 HPAPI MARKET, BY THERAPEUTIC APPLICATION, 2020–2027 (USD MILLION) 115
10.2 ONCOLOGY 115
・ TABLE 74 HPAPI MARKET FOR ONCOLOGY, BY REGION, 2020–2027 (USD MILLION) 116
・ TABLE 75 NORTH AMERICA: HPAPI MARKET FOR ONCOLOGY, BY COUNTRY,
2020–2027 (USD MILLION) 116
・ TABLE 76 EUROPE: HPAPI MARKET FOR ONCOLOGY, BY COUNTRY,
2020–2027 (USD MILLION) 117
・ TABLE 77 ASIA: HPAPI MARKET FOR ONCOLOGY, BY COUNTRY,
2020–2027 (USD MILLION) 117
10.3 HORMONAL IMBALANCE 118
・ TABLE 78 HPAPI MARKET FOR HORMONAL IMBALANCE, BY REGION,
2020–2027 (USD MILLION) 118
・ TABLE 79 NORTH AMERICA: HPAPI MARKET FOR HORMONAL IMBALANCE,
BY COUNTRY, 2020–2027 (USD MILLION) 119
・ TABLE 80 EUROPE: HPAPI MARKET FOR HORMONAL IMBALANCE, BY COUNTRY,
2020–2027 (USD MILLION) 119
・ TABLE 81 ASIA: HPAPI MARKET FOR HORMONAL IMBALANCE, BY COUNTRY,
2020–2027 (USD MILLION) 120
10.4 GLAUCOMA 120
・ TABLE 82 HPAPI MARKET FOR GLAUCOMA, BY REGION, 2020–2027 (USD MILLION) 120
・ TABLE 83 NORTH AMERICA: HPAPI MARKET FOR GLAUCOMA, BY COUNTRY,
2020–2027 (USD MILLION) 121
・ TABLE 84 EUROPE: HPAPI MARKET FOR GLAUCOMA, BY COUNTRY,
2020–2027 (USD MILLION) 121
・ TABLE 85 ASIA: HPAPI MARKET FOR GLAUCOMA, BY COUNTRY,
2020–2027 (USD MILLION) 122
10.5 OTHER THERAPEUTIC APPLICATIONS 122
・ TABLE 86 HPAPI MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION,
2020–2027 (USD MILLION) 123
・ TABLE 87 NORTH AMERICA: HPAPI MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 123
・ TABLE 88 EUROPE: HPAPI MARKET FOR OTHER THERAPEUTIC APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 124
・ TABLE 89 ASIA: HPAPI MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 124
11 HPAPI MARKET, BY REGION 125
11.1 INTRODUCTION 126
・ TABLE 90 HPAPI MARKET, BY REGION, 2020–2027 (USD MILLION) 126
11.2 NORTH AMERICA 126
・ FIGURE 23 NORTH AMERICA: HPAPI MARKET SNAPSHOT 127
・ TABLE 91 NORTH AMERICA: HPAPI MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 128
・ TABLE 92 NORTH AMERICA: HPAPI MARKET, BY TYPE, 2020–2027 (USD MILLION) 128
・ TABLE 93 NORTH AMERICA: HPAPI MARKET, BY TYPE OF MANUFACTURER,
2020–2027 (USD MILLION) 129
・ TABLE 94 NORTH AMERICA: MERCHANT APIS MANUFACTURERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 129
・ TABLE 95 NORTH AMERICA: MERCHANT APIS MANUFACTURERS MARKET,
BY TYPE OF SYNTHESIS, 2020–2027 (USD MILLION) 130
・ TABLE 96 NORTH AMERICA: HPAPI MARKET, BY TYPE OF SYNTHESIS,
2020–2027 (USD MILLION) 130
・ TABLE 97 NORTH AMERICA: SYNTHETIC APIS INGREDIENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 131
・ TABLE 98 NORTH AMERICA: BIOTECH APIS MARKET, BY TYPE,
2020–2027 (USD MILLION) 131
・ TABLE 99 NORTH AMERICA: BIOTECH HPAPI MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 132
・ TABLE 100 NORTH AMERICA: HPAPI MARKET, BY THERAPEUTIC APPLICATION,
2020–2027 (USD MILLION) 132
11.2.1 US 133
11.2.1.1 INCREASING INVESTMENTS IN CANCER RESEARCH TO DRIVE MARKET GROWTH 133
・ TABLE 101 US: HPAPI MARKET, BY TYPE, 2020–2027 (USD MILLION) 133
・ TABLE 102 US: HPAPI MARKET, BY TYPE OF MANUFACTURER,
2020–2027 (USD MILLION) 134
・ TABLE 103 US: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
・ TABLE 104 US: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD MILLION) 135
・ TABLE 105 US: HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD MILLION) 135
・ TABLE 106 US: SYNTHETIC APIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 136
・ TABLE 107 US: BIOTECH APIS MARKET, BY TYPE, 2020–2027 (USD MILLION 136
・ TABLE 108 US: BIOTECH APIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 137
・ TABLE 109 US: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY THERAPEUTIC APPLICATION, 2020–2027 (USD MILLION) 137
11.2.2 CANADA 138
11.2.2.1 THE RISING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH 138
・ TABLE 110 CANADA: HPAPI MARKET, BY TYPE, 2020–2027 (USD MILLION) 138
・ TABLE 111 CANADA: HPAPI MARKET, BY TYPE OF MANUFACTURER,
2020–2027 (USD MILLION) 138
・ TABLE 112 CANADA: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2020–2027 (USD MILLION) 139
・ TABLE 113 CANADA: MERCHANT API MANUFACTURERS MARKET,
BY TYPE OF SYNTHESIS, 2020–2027 (USD MILLION) 139
・ TABLE 114 CANADA: HPAPI MARKET, BY TYPE OF SYNTHESIS,
2020–2027 (USD MILLION) 140
・ TABLE 115 CANADA: SYNTHETIC APIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 140
・ TABLE 116 CANADA: BIOTECH APIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 141
・ TABLE 117 CANADA: BIOTECH APIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 141
・ TABLE 118 CANADA: HPAPI MARKET, BY THERAPEUTIC APPLICATION,
2020–2027 (USD MILLION) 142
11.3 EUROPE 142
・ FIGURE 24 EUROPE: HPAPI MARKET SNAPSHOT 143
・ TABLE 119 EUROPE: HPAPI MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 144
・ TABLE 120 EUROPE: HPAPI MARKET, BY TYPE, 2020–2027 (USD MILLION) 144
・ TABLE 121 EUROPE: HPAPI MARKET, BY TYPE OF MANUFACTURER,
2020–2027 (USD MILLION) 145
・ TABLE 122 EUROPE: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2020–2027 (USD MILLION) 145
・ TABLE 123 EUROPE: MERCHANT API MANUFACTURERS MARKET,
BY TYPE OF SYNTHESIS, 2020–2027 (USD MILLION) 146
・ TABLE 124 EUROPE: HPAPI MARKET, BY TYPE OF SYNTHESIS,
2020–2027 (USD MILLION) 146
・ TABLE 125 EUROPE: SYNTHETIC APIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 147
・ TABLE 126 EUROPE: BIOTECH APIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 147
・ TABLE 127 EUROPE: BIOTECH APIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 148
・ TABLE 128 EUROPE: HPAPI MARKET, BY THERAPEUTIC APPLICATION,
2020–2027 (USD MILLION) 148
11.3.1 GERMANY 149
11.3.1.1 THE STRONG FOCUS ON BIOTECH AND MEDICAL RESEARCH
TO DRIVE MARKET GROWTH 149
・ TABLE 129 GERMANY: HPAPI MARKET, BY TYPE, 2020–2027 (USD MILLION) 149
・ TABLE 130 GERMANY: HPAPI MARKET, BY TYPE OF MANUFACTURER,
2020–2027 (USD MILLION) 150
・ TABLE 131 GERMANY: MERCHANT API MANUFACTURERS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 150
・ TABLE 132 GERMANY: MERCHANT API MANUFACTURERS MARKET,
BY TYPE OF SYNTHESIS, 2020–2027 (USD MILLION) 151
・ TABLE 133 GERMANY: HPAPI MARKET, BY TYPE OF SYNTHESIS,
2020–2027 (USD MILLION) 151
・ TABLE 134 GERMANY: SYNTHETIC APIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 152
・ TABLE 135 GERMANY: BIOTECH APIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 152
・ TABLE 136 GERMANY: BIOTECH APIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 153
APPLICATION,
2020–2027 (USD MILLION) 153
11.3.2 FRANCE 154
11.3.2.1 THE PRESENCE OF MANY PHARMACEUTICAL COMPANIES COUPLED WITH THE GROWING DEMAND FOR NOVEL CANCER THERAPIES TO DRIVE MARKET GROWTH 154
・ TABLE 138 FRANCE: HPAPI MARKET, BY TYPE, 2020–2027 (USD MILLION) 154
・ TABLE 139 FRANCE: HPAPI MARKET, BY TYPE OF MANUFACTURER,
2020–2027 (USD MILLION) 154
・ TABLE 140 FRANCE: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2020–2027 (USD MILLION) 155
・ TABLE 141 FRANCE: MERCHANT HPAPI MANUFACTURERS MARKET,
BY TYPE OF SYNTHESIS, 2020–2027 (USD MILLION) 155
・ TABLE 142 FRANCE: HPAPI MARKET, BY TYPE OF SYNTHESIS,
2020–2027 (USD MILLION) 156
・ TABLE 143 FRANCE: SYNTHETIC APIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 156
・ TABLE 144 FRANCE: BIOTECH APIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 157
・ TABLE 145 FRANCE: BIOTECH APIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 157
・ TABLE 146 FRANCE: HPAPI MARKET, BY THERAPEUTIC APPLICATION,
2020–2027 (USD MILLION) 158
11.3.3 UK 158
11.3.3.1 INCREASING IN THE DEMAND FOR CANCER THERAPIES TO DRIVE MARKET GROWTH 158
・ TABLE 147 UK: HPAPI MARKET, BY TYPE, 2020–2027 (USD MILLION) 158
・ TABLE 148 UK: HPAPI MARKET, BY TYPE OF MANUFACTURER,
2020–2027 (USD MILLION) 159
・ TABLE 149 UK: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE,
2020–2027 (USD MILLION) 159
・ TABLE 150 UK: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD MILLION) 160
・ TABLE 151 UK: HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD MILLION) 160
・ TABLE 152 UK: SYNTHETIC APIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 161
・ TABLE 153 UK: BIOTECH APIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 161
・ TABLE 154 UK: BIOTECH APIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 162
・ TABLE 155 UK: HPAPI MARKET, BY THERAPEUTIC APPLICATION,
2020–2027 (USD MILLION) 162
11.3.4 ITALY 163
11.3.4.1 ROBUST GENERIC API PRODUCTION CAPACITIES TO DRIVE THE MARKET GROWTH 163
・ TABLE 156 ITALY: HPAPI MARKET, BY TYPE, 2020–2027 (USD MILLION) 163
・ TABLE 157 ITALY: HPAPI MARKET, BY TYPE OF MANUFACTURER,
2020–2027 (USD MILLION) 163
・ TABLE 158 ITALY: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
・ TABLE 159 ITALY: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD MILLION) 164
・ TABLE 160 ITALY: HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD MILLION) 165
・ TABLE 161 ITALY: SYNTHETIC APIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 165
・ TABLE 162 ITALY: BIOTECH APIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 166
・ TABLE 163 ITALY: BIOTECH APIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 166
・ TABLE 164 ITALY: HPAPI MARKET, BY THERAPEUTIC APPLICATION,
2020–2027 (USD MILLION) 167
11.3.5 SPAIN 167
11.3.5.1 DEVELOPMENTS IN THE ADC SEGMENT TO DRIVE MARKET GROWTH 167
・ TABLE 165 SPAIN: HPAPI MARKET, BY TYPE, 2020–2027 (USD MILLION) 167
・ TABLE 166 SPAIN: HPAPI MARKET, BY TYPE OF MANUFACTURER,
2020–2027 (USD MILLION) 168
・ TABLE 167 SPAIN: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2020–2027 (USD MILLION) 168
・ TABLE 168 SPAIN: MERCHANT MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD MILLION) 169
・ TABLE 169 SPAIN: HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD MILLION) 169
・ TABLE 170 SPAIN: SYNTHETIC APIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 170
・ TABLE 171 SPAIN: BIOTECH APIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 170
・ TABLE 172 SPAIN: BIOTECH APIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 171
・ TABLE 173 SPAIN: HPAPI MARKET, BY THERAPEUTIC APPLICATION,
2020–2027 (USD MILLION) 171
11.3.6 REST OF EUROPE 171
・ TABLE 174 REST OF EUROPE: HPAPI MARKET, BY TYPE, 2020–2027 (USD MILLION) 172
・ TABLE 175 REST OF EUROPE: HPAPI MARKET, BY TYPE OF MANUFACTURER,
2020–2027 (USD MILLION) 172
・ TABLE 176 REST OF EUROPE: MERCHANT API MANUFACTURERS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 173
・ TABLE 177 REST OF EUROPE: MERCHANT MANUFACTURERS MARKET,
BY TYPE OF SYNTHESIS, 2020–2027 (USD MILLION) 173
・ TABLE 178 REST OF EUROPE: HPAPI MARKET, BY TYPE OF SYNTHESIS,
2020–2027 (USD MILLION) 174
・ TABLE 179 REST OF EUROPE: SYNTHETIC APIS MARKET, BY TYPE,
2020–2027 (USD MILLION) 174
・ TABLE 180 REST OF EUROPE: BIOTECH APIS MARKET, BY TYPE,
2020–2027 (USD MILLION) 175
・ TABLE 181 REST OF EUROPE: BIOTECH APIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 175
・ TABLE 182 REST OF EUROPE: HPAPI MARKET, BY THERAPEUTIC APPLICATION,
2020–2027 (USD MILLION) 176
11.4 ASIA 176
・ FIGURE 25 ASIA: HPAPI MARKET SNAPSHOT 177
・ TABLE 183 ASIA: HPAPI MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 178
・ TABLE 184 ASIA: HPAPI MARKET, BY TYPE, 2020–2027 (USD MILLION) 178
・ TABLE 185 ASIA: HPAPI MARKET, BY TYPE OF MANUFACTURER,
2020–2027 (USD MILLION) 179
・ TABLE 186 ASIA: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2020–2027 (USD MILLION) 179
・ TABLE 187 ASIA: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD MILLION) 180
・ TABLE 188 ASIA: HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD MILLION) 180
・ TABLE 189 ASIA: SYNTHETIC APIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 181
・ TABLE 190 ASIA: BIOTECH APIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 181
・ TABLE 191 ASIA: BIOTECH APIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 182
・ TABLE 192 ASIA: HPAPI MARKET, BY THERAPEUTIC APPLICATION,
2020–2027 (USD MILLION) 182
11.4.1 JAPAN 183
11.4.1.1 INVESTMENTS IN THE DEVELOPMENT OF ADC PRODUCTS
TO DRIVE MARKET GROWTH 183
・ TABLE 193 JAPAN: HPAPI MARKET, BY TYPE, 2020–2027 (USD MILLION) 183
・ TABLE 194 JAPAN: HPAPI MARKET, BY TYPE OF MANUFACTURER,
2020–2027 (USD MILLION) 183
・ TABLE 195 JAPAN: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2020–2027 (USD MILLION) 184
・ TABLE 196 JAPAN: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD MILLION) 184
・ TABLE 197 JAPAN: HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD MILLION) 185
・ TABLE 198 JAPAN: SYNTHETIC APIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 185
・ TABLE 199 JAPAN: BIOTECH APIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 186
・ TABLE 200 JAPAN: BIOTECH APIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 186
・ TABLE 201 JAPAN: HPAPI MARKET, BY THERAPEUTIC APPLICATION,
2020–2027 (USD MILLION) 187
11.4.2 CHINA 187
11.4.2.1 LOW LABOR COSTS, PRESENCE OF WELL-EQUIPPED MANUFACTURING PLANTS TO DRIVE MARKET GROWTH 187
・ TABLE 202 CHINA: HPAPI MARKET, BY TYPE, 2020–2027 (USD MILLION) 187
・ TABLE 203 CHINA: HPAPI MARKET, BY TYPE OF MANUFACTURER,
2020–2027 (USD MILLION) 188
・ TABLE 204 CHINA: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2020–2027 (USD MILLION) 188
・ TABLE 205 CHINA: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD MILLION) 189
・ TABLE 206 CHINA: HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD MILLION) 189
・ TABLE 207 CHINA: SYNTHETIC APIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 190
・ TABLE 208 CHINA: BIOTECH APIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 190
・ TABLE 209 CHINA: BIOTECH APIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 191
・ TABLE 210 CHINA: HPAPI MARKET, BY THERAPEUTIC APPLICATION,
2020–2027 (USD MILLION) 191
11.4.3 INDIA 192
11.4.3.1 INCREASING INVESTMENTS IN ONCOLOGY TO DRIVE MARKET GROWTH 192
・ TABLE 211 INDIA: HPAPI MARKET, BY TYPE, 2020–2027 (USD MILLION) 192
・ TABLE 212 INDIA: HPAPI MARKET, BY TYPE OF MANUFACTURER,
2020–2027 (USD MILLION) 192
・ TABLE 213 INDIA: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2020–2027 (USD MILLION) 193
・ TABLE 214 INDIA: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD MILLION) 193
・ TABLE 215 INDIA: HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD MILLION) 194
・ TABLE 216 INDIA: SYNTHETIC APIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 194
・ TABLE 217 INDIA: BIOTECH APIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 195
・ TABLE 218 INDIA: BIOTECH APIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 195
・ TABLE 219 INDIA: HPAPI MARKET, BY THERAPEUTIC APPLICATION,
2020–2027 (USD MILLION) 196
11.4.4 REST OF ASIA 196
・ TABLE 220 REST OF ASIA: HPAPI MARKET, BY TYPE, 2020–2027 (USD MILLION) 197
・ TABLE 221 REST OF ASIA: HPAPI MARKET, BY TYPE OF MANUFACTURER,
2020–2027 (USD MILLION) 197
・ TABLE 222 REST OF ASIA: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2020–2027 (USD MILLION) 198
・ TABLE 223 REST OF ASIA: MERCHANT API MANUFACTURERS MARKET,
BY TYPE OF SYNTHESIS, 2020–2027 (USD MILLION) 198
・ TABLE 224 REST OF ASIA: HPAPI MARKET, BY TYPE OF SYNTHESIS,
2020–2027 (USD MILLION) 199
・ TABLE 225 REST OF ASIA: SYNTHETIC APIS MARKET, BY TYPE,
2020–2027 (USD MILLION) 199
・ TABLE 226 REST OF ASIA: BIOTECH APIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 200
・ TABLE 227 REST OF ASIA: BIOTECH APIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 200
・ TABLE 228 REST OF ASIA: HPAPI MARKET, BY THERAPEUTIC APPLICATION,
2020–2027 (USD MILLION) 201
11.5 REST OF THE WORLD 201
・ FIGURE 26 REST OF THE WORLD: HPAPI MARKET SNAPSHOT 202
・ TABLE 229 ROW: HPAPI MARKET, BY TYPE, 2020–2027 (USD MILLION) 202
・ TABLE 230 ROW: HPAPI MARKET, BY TYPE OF MANUFACTURER,
2020–2027 (USD MILLION) 203
・ TABLE 231 ROW: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2020–2027 (USD MILLION) 203
・ TABLE 232 ROW: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD MILLION) 204
・ TABLE 233 ROW: HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD MILLION) 204
・ TABLE 234 ROW: SYNTHETIC APIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 205
・ TABLE 235 ROW: BIOTECH APIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 205
・ TABLE 236 ROW: BIOTECH APIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 206
・ TABLE 237 ROW: HPAPI MARKET, BY THERAPEUTIC APPLICATION,
2020–2027 (USD MILLION) 206
12 COMPETITIVE LANDSCAPE 207
12.1 OVERVIEW 207
12.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN 207
・ FIGURE 27 KEY DEVELOPMENTS IN HPAPI MARKET, 2019–2022 207
12.3 MARKET SHARE ANALYSIS 208
・ FIGURE 28 HPAPI MARKET: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2021 208
・ TABLE 238 HPAPI MARKET: DEGREE OF COMPETITION 208
12.4 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 209
・ FIGURE 29 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN HPAPI MARKET, 2019–2021 209
12.5 COMPANY EVALUATION QUADRANT 210
12.5.1 STARS 210
12.5.2 EMERGING LEADERS 210
12.5.3 PERVASIVE PLAYERS 210
・ FIGURE 30 HPAPI MARKET: COMPANY EVALUATION QUADRANT 211
12.6 FOOTPRINT OF COMPANIES 212
・ TABLE 239 PORTFOLIO ANALYSIS BY TYPE OF SYNTHESIS: HPAPI MARKET (2021) 212
・ TABLE 240 PORTFOLIO ANALYSIS BY TYPE OF MANUFACTURER: HPAPI MARKET (2021) 212
・ TABLE 241 PORTFOLIO ANALYSIS BY TYPE OF THERAPEUTIC APPLICATIONS: HPAPI MARKET (2021) 213
12.7 REGIONAL FOOTPRINT 214
・ TABLE 242 REGIONAL FOOTPRINT OF COMPANIES: HPAPI MARKET (2021) 214
12.8 COMPETITIVE SCENARIO 215
・ TABLE 243 PRODUCT LAUNCHES 215
・ TABLE 244 DEALS 216
13 COMPANY PROFILES 217
13.1 MAJOR PLAYERS 217
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS))*
13.1.1 PFIZER INC. 217
・ TABLE 245 PFIZER INC.: BUSINESS OVERVIEW 217
・ FIGURE 31 PFIZER INC.: COMPANY SNAPSHOT (2021) 218
13.1.2 NOVARTIS INTERNATIONAL AG 224
・ TABLE 246 NOVARTIS INTERNATIONAL AG: BUSINESS OVERVIEW 224
・ FIGURE 32 NOVARTIS INTERNATIONAL AG: COMPANY SNAPSHOT (2021) 225
13.1.3 SANOFI 228
・ TABLE 247 SANOFI: BUSINESS OVERVIEW 228
・ FIGURE 33 SANOFI: COMPANY SNAPSHOT (2021) 229
13.1.4 F. HOFFMANN-LA ROCHE 235
・ TABLE 248 F. HOFFMANN-LA ROCHE: BUSINESS OVERVIEW 235
・ FIGURE 34 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2021) 236
13.1.5 BRISTOL-MYERS SQUIBB COMPANY 242
・ TABLE 249 BRISTOL-MYERS SQUIBB COMPANY: BUSINESS OVERVIEW 242
・ FIGURE 35 BRISTOL-MYERS SQUIBB COMPANY: COMPANY SNAPSHOT (2021) 242
13.1.6 BOEHRINGER-INGELHEIM 245
・ TABLE 250 BOEHRINGER-INGELHEIM: BUSINESS OVERVIEW 245
・ FIGURE 36 BOEHRINGER-INGELHEIM: COMPANY SNAPSHOT (2021) 246
13.1.7 TEVA PHARMACEUTICAL INDUSTRY LTD. 249
・ TABLE 251 TEVA PHARMACEUTICAL INDUSTRY LTD.: BUSINESS OVERVIEW 249
・ FIGURE 37 TEVA PHARMACEUTICAL INDUSTRY LTD.: COMPANY SNAPSHOT (2021) 249
13.1.8 ELI LILY AND COMPANY 253
・ TABLE 252 ELI LILY AND COMPANY: BUSINESS OVERVIEW 253
・ FIGURE 38 ELI LILY AND COMPANY: COMPANY SNAPSHOT (2021) 253
13.1.9 MERCK & CO., INC. 257
・ TABLE 253 MERCK & CO., INC.: BUSINESS OVERVIEW 257
・ FIGURE 39 MERCK & CO., INC.: COMPANY SNAPSHOT (2021) 258
13.1.10 ABBVIE INC. 262
・ TABLE 254 ABBVIE INC.: BUSINESS OVERVIEW 262
・ FIGURE 40 ABBVIE INC.: COMPANY SNAPSHOT (2021) 263
13.1.11 VIATRIS INC. 267
・ TABLE 255 VIATRIS INC.: BUSINESS OVERVIEW 267
・ FIGURE 41 VIATRIS INC.: COMPANY SNAPSHOT (2021) 268
13.1.12 BAYER 270
・ TABLE 256 BAYER AG: BUSINESS OVERVIEW 270
・ FIGURE 42 BAYER AG: COMPANY SNAPSHOT (2021) 271
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS) MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
14 APPENDIX 273